Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DNY63Z
|
|||
| Drug Name |
CC-94676
|
|||
| Indication | Invasive prostate cancer [ICD-11: 2C82; ICD-10: C61] | Phase 1 | [1] | |
| Prostate cancer [ICD-11: 2C82.0; ICD-9: 185] | Phase 1 | [1] | ||
| Company |
Bristol-Myers Squibb
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04428788) Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CC-94676 in Subjects With Metastatic Castration-Resistant Prostate Cancer. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.